Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 21 | 2023 | 561 | 6.310 |
Why?
|
| Caregivers | 11 | 2022 | 365 | 3.230 |
Why?
|
| Cancer Survivors | 8 | 2022 | 146 | 2.860 |
Why?
|
| Quality of Life | 16 | 2023 | 1515 | 2.590 |
Why?
|
| Body Image | 6 | 2023 | 100 | 2.480 |
Why?
|
| Survivors | 7 | 2023 | 256 | 1.990 |
Why?
|
| Patient Reported Outcome Measures | 6 | 2021 | 114 | 1.830 |
Why?
|
| Telemedicine | 5 | 2023 | 700 | 1.520 |
Why?
|
| Spouses | 5 | 2010 | 51 | 1.350 |
Why?
|
| Survivorship | 2 | 2019 | 20 | 1.220 |
Why?
|
| Social Support | 7 | 2020 | 423 | 1.200 |
Why?
|
| Breast Neoplasms | 8 | 2015 | 1536 | 1.190 |
Why?
|
| Needs Assessment | 3 | 2019 | 186 | 1.160 |
Why?
|
| Interpersonal Relations | 3 | 2017 | 209 | 1.050 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 445 | 1.040 |
Why?
|
| Adaptation, Psychological | 5 | 2020 | 447 | 1.010 |
Why?
|
| Early Detection of Cancer | 3 | 2021 | 454 | 0.960 |
Why?
|
| Middle Aged | 40 | 2023 | 21147 | 0.950 |
Why?
|
| Critical Care | 3 | 2021 | 263 | 0.910 |
Why?
|
| Female | 49 | 2023 | 38074 | 0.900 |
Why?
|
| Humans | 71 | 2023 | 68618 | 0.890 |
Why?
|
| Body Dysmorphic Disorders | 2 | 2020 | 13 | 0.880 |
Why?
|
| Aged | 29 | 2023 | 14862 | 0.870 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 778 | 0.860 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 77 | 0.840 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2009 | 157 | 0.830 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 170 | 0.830 |
Why?
|
| Adult | 33 | 2023 | 21403 | 0.780 |
Why?
|
| Male | 41 | 2023 | 37321 | 0.770 |
Why?
|
| Quality Improvement | 3 | 2020 | 413 | 0.770 |
Why?
|
| Quality of Health Care | 2 | 2015 | 322 | 0.750 |
Why?
|
| Asthma | 2 | 2021 | 345 | 0.720 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 378 | 0.720 |
Why?
|
| Aged, 80 and over | 13 | 2023 | 4848 | 0.690 |
Why?
|
| Qualitative Research | 6 | 2023 | 369 | 0.680 |
Why?
|
| Pilot Projects | 7 | 2023 | 1342 | 0.670 |
Why?
|
| Colorectal Neoplasms | 5 | 2019 | 561 | 0.670 |
Why?
|
| Attitude to Health | 4 | 2016 | 403 | 0.650 |
Why?
|
| Psychology | 1 | 2018 | 36 | 0.640 |
Why?
|
| Advance Care Planning | 1 | 2018 | 11 | 0.630 |
Why?
|
| Decision Making | 6 | 2022 | 410 | 0.620 |
Why?
|
| Intensive Care Units | 6 | 2021 | 344 | 0.610 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 149 | 0.600 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2020 | 468 | 0.600 |
Why?
|
| Spirituality | 2 | 2014 | 38 | 0.560 |
Why?
|
| Critical Illness | 3 | 2022 | 191 | 0.520 |
Why?
|
| Smoking | 4 | 2018 | 1452 | 0.520 |
Why?
|
| Women's Health | 2 | 2023 | 148 | 0.510 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 629 | 0.490 |
Why?
|
| Psychometrics | 4 | 2020 | 514 | 0.480 |
Why?
|
| Smoking Cessation | 4 | 2022 | 1034 | 0.480 |
Why?
|
| Neoplasms | 6 | 2020 | 1667 | 0.470 |
Why?
|
| Health Status | 1 | 2017 | 429 | 0.470 |
Why?
|
| South Carolina | 10 | 2020 | 2752 | 0.470 |
Why?
|
| Social Environment | 2 | 2012 | 182 | 0.460 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 1242 | 0.450 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 299 | 0.440 |
Why?
|
| Patient-Centered Care | 2 | 2019 | 106 | 0.430 |
Why?
|
| Perception | 3 | 2021 | 189 | 0.410 |
Why?
|
| Self Efficacy | 4 | 2018 | 199 | 0.410 |
Why?
|
| Population Surveillance | 3 | 2019 | 285 | 0.380 |
Why?
|
| Surveys and Questionnaires | 11 | 2019 | 2800 | 0.370 |
Why?
|
| Androgen Antagonists | 1 | 2010 | 45 | 0.350 |
Why?
|
| Health Promotion | 3 | 2016 | 407 | 0.350 |
Why?
|
| Prostatectomy | 1 | 2010 | 87 | 0.350 |
Why?
|
| Prospective Studies | 5 | 2022 | 3705 | 0.340 |
Why?
|
| Postoperative Period | 1 | 2010 | 238 | 0.340 |
Why?
|
| Respiratory Insufficiency | 2 | 2021 | 76 | 0.340 |
Why?
|
| Socioeconomic Factors | 6 | 2021 | 955 | 0.330 |
Why?
|
| Patient Transfer | 2 | 2021 | 86 | 0.330 |
Why?
|
| Culture | 4 | 2016 | 75 | 0.320 |
Why?
|
| Social Control, Formal | 1 | 2008 | 12 | 0.310 |
Why?
|
| Sick Role | 1 | 2008 | 40 | 0.310 |
Why?
|
| Patient Selection | 3 | 2016 | 592 | 0.300 |
Why?
|
| Factor Analysis, Statistical | 3 | 2020 | 201 | 0.270 |
Why?
|
| Risk Factors | 8 | 2021 | 5731 | 0.270 |
Why?
|
| Ovarian Neoplasms | 3 | 2016 | 267 | 0.250 |
Why?
|
| Health Behavior | 2 | 2008 | 458 | 0.250 |
Why?
|
| Cross-Sectional Studies | 7 | 2021 | 2279 | 0.240 |
Why?
|
| School Health Services | 2 | 2021 | 72 | 0.230 |
Why?
|
| Depression | 3 | 2019 | 943 | 0.220 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 529 | 0.220 |
Why?
|
| Hospitals, Community | 2 | 2020 | 64 | 0.220 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 1054 | 0.220 |
Why?
|
| Interdisciplinary Communication | 2 | 2020 | 93 | 0.220 |
Why?
|
| Tobacco Use | 3 | 2022 | 98 | 0.210 |
Why?
|
| Family | 3 | 2021 | 293 | 0.210 |
Why?
|
| Child | 3 | 2023 | 6405 | 0.210 |
Why?
|
| Hearing Aids | 1 | 2022 | 34 | 0.210 |
Why?
|
| Health Services Research | 2 | 2015 | 209 | 0.210 |
Why?
|
| Program Development | 2 | 2020 | 240 | 0.200 |
Why?
|
| Leadership | 2 | 2020 | 136 | 0.200 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 146 | 0.200 |
Why?
|
| Demography | 2 | 2016 | 279 | 0.200 |
Why?
|
| Young Adult | 6 | 2021 | 5717 | 0.200 |
Why?
|
| Self Report | 2 | 2021 | 371 | 0.200 |
Why?
|
| Physicians | 2 | 2015 | 324 | 0.200 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2022 | 72 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2022 | 652 | 0.200 |
Why?
|
| Patient Care Team | 2 | 2015 | 311 | 0.190 |
Why?
|
| Time-to-Treatment | 2 | 2020 | 117 | 0.190 |
Why?
|
| Time Factors | 4 | 2020 | 4655 | 0.190 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 951 | 0.190 |
Why?
|
| Cochlear Implantation | 1 | 2022 | 99 | 0.190 |
Why?
|
| Cochlear Implants | 1 | 2022 | 110 | 0.190 |
Why?
|
| Mental Health | 2 | 2016 | 278 | 0.190 |
Why?
|
| Prostate-Specific Antigen | 1 | 2021 | 138 | 0.180 |
Why?
|
| Self-Management | 1 | 2022 | 82 | 0.180 |
Why?
|
| Program Evaluation | 2 | 2020 | 502 | 0.180 |
Why?
|
| Schools | 1 | 2021 | 156 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 786 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2020 | 110 | 0.170 |
Why?
|
| Postoperative Complications | 2 | 2019 | 1615 | 0.170 |
Why?
|
| Genetic Testing | 2 | 2003 | 159 | 0.170 |
Why?
|
| Speech Perception | 1 | 2022 | 261 | 0.170 |
Why?
|
| Patient Compliance | 2 | 2019 | 402 | 0.170 |
Why?
|
| Confidentiality | 1 | 1999 | 62 | 0.170 |
Why?
|
| Exercise Therapy | 2 | 2011 | 183 | 0.160 |
Why?
|
| Professional-Family Relations | 1 | 2019 | 45 | 0.160 |
Why?
|
| Social Isolation | 1 | 2019 | 40 | 0.160 |
Why?
|
| Ethics, Medical | 1 | 1999 | 86 | 0.160 |
Why?
|
| Guideline Adherence | 2 | 2018 | 287 | 0.160 |
Why?
|
| Cognition | 1 | 2023 | 513 | 0.160 |
Why?
|
| Adolescent | 4 | 2021 | 8912 | 0.160 |
Why?
|
| Registries | 2 | 2016 | 733 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2019 | 99 | 0.160 |
Why?
|
| Colonoscopy | 1 | 2019 | 156 | 0.160 |
Why?
|
| Informed Consent | 1 | 1999 | 127 | 0.160 |
Why?
|
| Family Relations | 1 | 2018 | 47 | 0.150 |
Why?
|
| Cancer Care Facilities | 1 | 2018 | 32 | 0.150 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 190 | 0.150 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 800 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2018 | 104 | 0.150 |
Why?
|
| Tobacco Use Disorder | 1 | 2022 | 432 | 0.150 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2018 | 94 | 0.150 |
Why?
|
| Pregnancy | 1 | 2023 | 2334 | 0.140 |
Why?
|
| Rural Population | 1 | 2020 | 398 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2016 | 848 | 0.140 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 206 | 0.130 |
Why?
|
| Social Class | 1 | 2016 | 127 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 931 | 0.130 |
Why?
|
| Mass Screening | 1 | 2021 | 843 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 3259 | 0.130 |
Why?
|
| Self Disclosure | 1 | 2015 | 55 | 0.130 |
Why?
|
| Evaluation Studies as Topic | 1 | 2015 | 219 | 0.120 |
Why?
|
| Focus Groups | 3 | 2016 | 247 | 0.120 |
Why?
|
| Communication | 2 | 2015 | 329 | 0.120 |
Why?
|
| Models, Organizational | 1 | 2015 | 97 | 0.120 |
Why?
|
| HIV Infections | 1 | 2022 | 791 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2015 | 113 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 767 | 0.120 |
Why?
|
| Genes, BRCA1 | 2 | 1999 | 47 | 0.110 |
Why?
|
| BRCA2 Protein | 1 | 2003 | 18 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2003 | 30 | 0.110 |
Why?
|
| Public Health Administration | 1 | 2013 | 36 | 0.110 |
Why?
|
| United States | 5 | 2021 | 7367 | 0.110 |
Why?
|
| Uncertainty | 1 | 2013 | 31 | 0.110 |
Why?
|
| Referral and Consultation | 3 | 2021 | 383 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 120 | 0.100 |
Why?
|
| Emotions | 2 | 2018 | 244 | 0.100 |
Why?
|
| Mass Media | 1 | 2012 | 29 | 0.100 |
Why?
|
| Ships | 1 | 2011 | 5 | 0.100 |
Why?
|
| Unnecessary Procedures | 1 | 2012 | 49 | 0.100 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 442 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 306 | 0.100 |
Why?
|
| Massage | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2017 | 659 | 0.100 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2011 | 16 | 0.100 |
Why?
|
| Tobacco | 2 | 2022 | 161 | 0.100 |
Why?
|
| Community Networks | 1 | 2012 | 96 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 37 | 0.100 |
Why?
|
| Group Processes | 1 | 2011 | 42 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2022 | 7029 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2012 | 115 | 0.100 |
Why?
|
| Disclosure | 1 | 2011 | 45 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 319 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2012 | 111 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 307 | 0.090 |
Why?
|
| Stress, Psychological | 3 | 2018 | 824 | 0.090 |
Why?
|
| Research Design | 1 | 2015 | 729 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 2077 | 0.090 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 1506 | 0.090 |
Why?
|
| Sexuality | 1 | 2010 | 12 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2013 | 326 | 0.090 |
Why?
|
| APACHE | 1 | 2010 | 41 | 0.090 |
Why?
|
| Life Style | 1 | 2012 | 338 | 0.090 |
Why?
|
| Mothers | 1 | 2011 | 172 | 0.090 |
Why?
|
| Medicare | 1 | 2012 | 319 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2010 | 117 | 0.090 |
Why?
|
| Educational Status | 1 | 2010 | 273 | 0.080 |
Why?
|
| Walking | 1 | 2011 | 241 | 0.080 |
Why?
|
| Affect | 1 | 2010 | 218 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 468 | 0.080 |
Why?
|
| Internal-External Control | 1 | 2008 | 60 | 0.080 |
Why?
|
| Diet | 1 | 2011 | 514 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1040 | 0.070 |
Why?
|
| Marriage | 1 | 2007 | 30 | 0.070 |
Why?
|
| Motor Activity | 1 | 2010 | 621 | 0.070 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2006 | 4 | 0.070 |
Why?
|
| Family Health | 1 | 2007 | 83 | 0.070 |
Why?
|
| Vasculitis | 1 | 2006 | 33 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2008 | 298 | 0.070 |
Why?
|
| Health Educators | 1 | 2005 | 3 | 0.060 |
Why?
|
| Planning Techniques | 1 | 2005 | 16 | 0.060 |
Why?
|
| Cotinine | 2 | 2015 | 40 | 0.060 |
Why?
|
| Professional Practice | 1 | 2005 | 47 | 0.060 |
Why?
|
| Teaching | 1 | 2005 | 169 | 0.060 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2022 | 13 | 0.050 |
Why?
|
| Resuscitation Orders | 1 | 2022 | 12 | 0.050 |
Why?
|
| Varenicline | 1 | 2022 | 98 | 0.050 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2021 | 33 | 0.050 |
Why?
|
| Nicotinic Agonists | 1 | 2022 | 111 | 0.050 |
Why?
|
| Prostate | 1 | 2022 | 116 | 0.050 |
Why?
|
| Free Tissue Flaps | 1 | 2021 | 67 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 35 | 0.050 |
Why?
|
| Hospitals, Rural | 1 | 2021 | 43 | 0.050 |
Why?
|
| Inpatients | 1 | 2022 | 208 | 0.050 |
Why?
|
| Nomograms | 1 | 2020 | 19 | 0.050 |
Why?
|
| Motivation | 3 | 2011 | 561 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2018 | 2358 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 521 | 0.040 |
Why?
|
| Risk Adjustment | 1 | 2020 | 49 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 1046 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2019 | 201 | 0.040 |
Why?
|
| Hospice Care | 1 | 2018 | 29 | 0.040 |
Why?
|
| Patient Navigation | 1 | 2018 | 30 | 0.040 |
Why?
|
| Counseling | 1 | 2020 | 280 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 392 | 0.040 |
Why?
|
| Genetic Counseling | 1 | 2018 | 45 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 1999 | 261 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 978 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 1465 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 581 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 1056 | 0.030 |
Why?
|
| SEER Program | 1 | 2016 | 153 | 0.030 |
Why?
|
| Telephone | 1 | 2016 | 160 | 0.030 |
Why?
|
| Palliative Care | 1 | 2018 | 271 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 63 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 235 | 0.030 |
Why?
|
| Medicine | 1 | 2015 | 52 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2018 | 7277 | 0.030 |
Why?
|
| Financing, Government | 1 | 2013 | 16 | 0.030 |
Why?
|
| Health Priorities | 1 | 2013 | 23 | 0.030 |
Why?
|
| Resource Allocation | 1 | 2013 | 35 | 0.030 |
Why?
|
| State Government | 1 | 2013 | 34 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2013 | 70 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 159 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 489 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1851 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1553 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 136 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 536 | 0.030 |
Why?
|
| Risk | 1 | 2003 | 563 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 780 | 0.020 |
Why?
|
| Mexico | 1 | 2011 | 38 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 792 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 24 | 0.020 |
Why?
|
| Taxoids | 1 | 2011 | 41 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 92 | 0.020 |
Why?
|
| Food | 1 | 2011 | 52 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 446 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 192 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 150 | 0.020 |
Why?
|
| Language | 1 | 2011 | 120 | 0.020 |
Why?
|
| Smoking Prevention | 1 | 2011 | 259 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 737 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2011 | 224 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1864 | 0.020 |
Why?
|
| Health Education | 1 | 2011 | 279 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 2093 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 390 | 0.020 |
Why?
|
| Mutation | 2 | 1999 | 1213 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 475 | 0.020 |
Why?
|
| Knowledge | 1 | 1997 | 18 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1619 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1997 | 179 | 0.020 |
Why?
|
| Empathy | 1 | 2006 | 45 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3187 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1997 | 425 | 0.010 |
Why?
|
| Research | 1 | 2005 | 214 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 1330 | 0.010 |
Why?
|
| Curriculum | 1 | 2005 | 575 | 0.010 |
Why?
|
| Research Subjects | 1 | 1999 | 45 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1999 | 144 | 0.010 |
Why?
|
| Risk Assessment | 1 | 1999 | 2007 | 0.010 |
Why?
|